Salus Laboratory is a startup company established in January 2022 as a venture originating from Osaka Metropolitan University. Based on research and development of plant-derived functional materials, the company promotes the development and commercialization of multifunctional foods in the health and beauty fields. Guided by scientific evidence, we aim to create products that support cognitive health and extend healthy life expectancy. Our mission is to contribute to healthy longevity by scientifically advancing the concept of “food as medicine.”
L-glucose, a mirror isomer of D-glucose, is usually considered unusable by living organisms. However, in 2010, we discovered that malignant tumor cells specifically take up L-glucose (patented internationally). We have since worked with physicians and researchers to develop cancer-targeting drugs and diagnostics using L-glucose. Our goal is to bring a cure to patients with intractable cancers.
A startup that synthesizes long, complex DNA using proprietary technology, enabling the flexible design of diverse gene combinations. It also provides comprehensive support from development to manufacturing processes for viral vectors and mRNA required for gene therapy.
Our key product is Enteral Ventilation (EVA) technology, that supplies liquid oxygen to premature babies with serious respiratory problems through Gut-Mediated Oxygen Delivery. The program is at the clinical trial stage.
A drug discovery startup that uses proprietary technology to analyze molecular motion, uncovering previously untargeted disease-causing factors and developing therapeutic drugs. We conduct integrated research from basic studies to clinical development, aiming to create novel treatments.
